Charlotte's Web Holdings, Inc. (CWBHF)
| Market Cap | $47.56M+94.4% |
| Revenue (ttm) | $44.73M |
| Net Income | -$32.12M |
| EPS | -$0.17 |
| Shares Out | 271.80M |
| PE Ratio | n/a |
| Forward PE | 17.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 67,403 |
| Open | $0.17 |
| Previous Close | $0.18 |
| Day's Range | $0.17 - $0.18 |
| 52-Week Range | $0.09 - $0.97 |
| Beta | 2.35 |
| Analysts | Strong Buy |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
About CWBHF
Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States. The company offers full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushroom gummies; and pet products. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. The company markets its products under the Charlotte's Web, Brightside, CBD Clinic, and CBD Medic brands. It distributes its products through its e-commerce website, third-party e-commerce websites, distributors, retailers, and healthcare practitioners. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.
Charlotte's Web Holdings, Inc. Stock Analysis — InsiderScore
Charlotte's Web Holdings, Inc. scored higher than 1% of companies evaluated by InsiderBuying, and ranked 98th out of 103 stocks in the biotech sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Charlotte's Web Holdings, Inc. bought $39.3K of stock across 1 purchase in the last 90 days, the largest of them $39.3K.
The average purchase added about 18% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CWBHF stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CWBHF holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CWBHF's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CWBHF Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CWBHF Revenue by Segment
| Other segment information | $72.44M | 77.27% |
| Long-term liabilities | $11.82M | 12.61% |
| Product Revenue | $9.32M | 9.94% |
| Change in fair value of financial instruments | $100.00K | 0.11% |
| Service Revenue | $75.00K | 0.08% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CWBHF patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CWBHF from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from CWBHF’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 net loss narrowed, suggesting operational improvement; regulatory support demonstrates favorable industry positioning.
Recent Insider Activity
Insider Score Trend Over Time
+7.2 since Sep 14Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
